SCHEMBL31163087

SCHEMBL31163087

COc1cc(Nc2ncc(C)c(Nc3cccc(S(=O)(=O)NC(C)(C)C)c3)n2)cc(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 7/20 0.63
▸ BRD4 O60885 12/20 0.62
▸ JAK1 P23458 8/20 0.62
▸ JAK3 P52333 6/20 0.62
▸ RET P07949 2/20 0.62
▸ WEE1 P30291 2/20 0.62
▸ FLT3 P36888 2/20 0.62
▸ BRDT Q58F21 2/20 0.62
▸ ALK Q9UM73 2/20 0.62
▸ BUB1B O60566 1/20 0.62
▸ BRD2 P25440 1/20 0.62
▸ BRD3 Q15059 1/20 0.62
▸ TYK2 P29597 3/20 0.60
▸ SYK P43405 2/20 0.60
▸ BMPR1B O00238 1/20 0.60
▸ PLK4 O00444 1/20 0.60
▸ STK25 O00506 1/20 0.60
▸ CIT O14578 1/20 0.60
▸ RIOK3 O14730 1/20 0.60
▸ CHEK1 O14757 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31163079 0.92 JAK2 (0.66) JAK2BRD4JAK1JAK3RET
SCHEMBL31163113 0.90 JAK1 (0.71) JAK2BRD4JAK1JAK3RET
SCHEMBL25382998 0.89 BRD4 (0.74) JAK2BRD4JAK1JAK3RET
SCHEMBL30565206 0.89 BRD4 (0.74) JAK2BRD4JAK1JAK3RET
SCHEMBL30565204 0.89 BRD4 (0.74) JAK2BRD4JAK1JAK3RET
SCHEMBL31163137 0.89 JAK2 (0.59) JAK2BRD4JAK1JAK3RET
SCHEMBL30565216 0.89 JAK2 (0.67) JAK2BRD4JAK1JAK3RET
SCHEMBL25381399 0.89 JAK2 (0.67) JAK2BRD4JAK1JAK3RET
SCHEMBL20288209 0.87 JAK2 (0.75) JAK2BRD4JAK1JAK3RET
SCHEMBL13031088 0.86 BRD4 (0.73) JAK2BRD4JAK1JAK3RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
Send feedback